Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting benefit from PARP inhibitors using deep learning on H&E-stained ovarian cancer slides.
Marmé F, Krieghoff-Henning EI, Kiehl L, Wies C, Hauke J, Hahnen E, Harter P, Schouten PC, Brodkorb T, Kayali M, Heitz F, Zamagni C, González-Martin A, Treilleux I, Kommoss S, Prieske K, Gaiser T, Fröhling S, Ray-Coquard I, Pujade-Lauraine E, Brinker TJ. Marmé F, et al. Among authors: harter p. Eur J Cancer. 2024 Dec 26;216:115199. doi: 10.1016/j.ejca.2024.115199. Online ahead of print. Eur J Cancer. 2024. PMID: 39742559 Free article.
Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation.
Holzgreve A, Harter PN, Forbrig R, Quach S, Thon N, Schichor C, Tonn JC, Niyazi M, Brendel M, von Baumgarten L, Albert NL. Holzgreve A, et al. Among authors: harter pn. Eur J Nucl Med Mol Imaging. 2024 Nov 26. doi: 10.1007/s00259-024-06998-y. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39589520 No abstract available.
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients.
Klinsing S, Beck J, Weber KJ, Bornemann-Kolatzki K, Dettki M, Urban H, Roller B, Chow KU, Reis H, Wild PJ, Schuetz E, Euskirchen P, Steinbach JP, Ronellenfitsch MW, Harter PN, Zeiner PS. Klinsing S, et al. Among authors: harter pn. Acta Neuropathol Commun. 2024 Nov 20;12(1):177. doi: 10.1186/s40478-024-01887-9. Acta Neuropathol Commun. 2024. PMID: 39568088 Free PMC article.
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments.
Müller KJ, Forbrig R, Reis J, Wiegand L, Barci E, Kunte SC, Kaiser L, Schönecker S, Schichor C, Harter PN, Thon N, von Baumgarten L, Preusser M, Albert NL. Müller KJ, et al. Among authors: harter pn. Neuro Oncol. 2025 Jan 12;27(1):77-88. doi: 10.1093/neuonc/noae208. Neuro Oncol. 2025. PMID: 39561103
An AMP-activated protein kinase-PGC-1α axis mediates metabolic plasticity in glioblastoma.
Sauer B, Kueckelhaus J, Lorenz NI, Bozkurt S, Schulte D, Weinem JB, Benzarti M, Meiser J, Urban H, Villa G, Harter PN, Münch C, Rieger J, Steinbach JP, Heiland DH, Ronellenfitsch MW. Sauer B, et al. Among authors: harter pn. Clin Transl Med. 2024 Nov;14(11):e70030. doi: 10.1002/ctm2.70030. Clin Transl Med. 2024. PMID: 39552019 Free PMC article.
Study protocol of an exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA) - a randomized controlled trial.
Maurer T, Belau MH, Zyriax BC, Welsch G, Jagemann B, Chang-Claude J, Daubmann A, Buchholz A, Glismann K, Moeller A, Sehouli J, Woopen H, Wimberger P, Harter P, Kaiser S, Maass N, Kiechle M, Engler T, Schmalfeldt B, Schulz H. Maurer T, et al. Among authors: harter p. BMC Cancer. 2024 Nov 11;24(1):1379. doi: 10.1186/s12885-024-13102-y. BMC Cancer. 2024. PMID: 39528997 Free PMC article.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.10.828. Online ahead of print. Ann Oncol. 2024. PMID: 39528049 Free article.
594 results